Goal & Research Areas

Structural Biology Core offers the unique capabilities in X-ray macromolecular crystallography, spectroscopy and imaging, small angle scattering and cryogenic electron microscopy and tomography which are housed at the SLAC campus of Stanford University. We believe structure-based design and optimization of therapeutic reagents are exciting and standard approaches in pharmaceutical discoveries. Our Core has dedicated personnel to work with you and your lab staff on solving the structures of RNAs, proteins, macromolecular machines, organelles and cellular organization with and without intervention agents

Hot Topic

Jeffrey Glenn receives $69 million to start antiviral drug-discovery center at Stanford

The National Institute for Allergy and Infectious Diseases has awarded Jeffrey Glenn, MD, PhD, professor of hepatology and gastroenterology and of microbiology and immunology, $69 million...

Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial

A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.

Antiviral Program for Pandemics

The Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2, the virus that causes COVID-19, as well as to build sustainable platforms for targeted drug discovery and development of a robust pipeline of antivirals against viruses with pandemic potential.

ViRx Home Page

Structural Biology Core

Goal & Research Areas

Core Leader & Team

Wah Chiu

Britt Hedman

Keith Hodgson

Crissy Tarver

Hot Topic

Jeffrey Glenn receives $69 million to start antiviral drug-discovery center at Stanford

Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial

Antiviral Program for Pandemics